SPRINTR is a nationwide research study in Sweden that explores the best ways to investigate and treat prostate cancer based on each patient's individual situation.
The study has approval from the Swedish Ethical Review Authority and is conducted through collaboration between healthcare providers and universities in Sweden.
Who can join SPRINTR? If you've had a PSA test, are being evaluated for suspected prostate cancer, or have already been diagnosed with prostate cancer, you are eligible to participate. If you haven't been contacted or informed about the study by your healthcare provider but still want to join, you can reach out to the nearest participating clinic (link coming soon).
What does participation involve? Participation is voluntary and does not interfere with your regular care. If you decide to participate, you are providing consent for your samples and health information to be used for research. You may also be contacted later about participating in other studies. All data is handled in accordance with Swedish law and is coded to protect your personal information. By taking part, you help improve the development of more accurate and gentler prostate cancer treatments.
